Age

18–70

Sex

FEMALE

Healthy volunteers

Not accepted

Female, aged ≥18 and ≤70 years;
Histologically confirmed invasive breast cancer (cT2-4N0-2M0 or cT1N1-3M0 before neoadjuvant treatment);
Completed neoadjuvant treamtment and surgery (within 4 years after surgery);
Administered neoadjuvant chemotherapy (regardless of chemotherapy regimen);
ECOG 0-1

CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial